{"database": "openregs", "table": "documents", "rows": [["CMS-2022-0194-0001", "CMS", "CMS-2022-0194", "Medicare Advantage and Prescription Drug Program: Final Marketing Provisions CFR 422.111(a)(3) and 423.128(a)(3) (CMS-10260)", "Notice", null, "2022-12-15T05:00:00Z", 2022, 12, "2022-12-15T05:00:00Z", "2023-02-14T04:59:59Z", "2023-02-16T02:00:47Z", "2022-27166", 0, 0, "0900006485538493"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["CMS-2022-0194-0001"], "units": {}, "query_ms": 0.3674430772662163, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}